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ABSTRACT The biological and molecular properties of tetrodotoxin (TTX)-sensitive voltage-gated Na1 currents (INa) in murine
vas deferens myocytes were investigated using patch-clamp techniques and molecular biological analyses. In whole-cell
conﬁguration, a fast, transient inward current was evoked in the presence of Cd21, and was abolished by TTX (Kd ¼ 11.2 nM),
mibefradil (Kd¼ 3.3mM), and external replacement of Na1withmonovalent cations (TEA1, Tris1, andNMDG1). The fast transient
inward current was enhanced by veratridine, an activator of voltage-gated Na1 channels, suggesting that the fast transient inward
currentwas aTTX-sensitive INa. The values for half-maximal (Vhalf) inactivation andactivation of INawere46.3mVand26.0mV,
respectively. RT-PCR analysis revealed the expression of Scn1a, 2a, and 8a transcripts. The Scn8a transcript and the a-subunit
protein of NaV1.6 were detected in smooth muscle layers. Using NaV1.6-null mice (NaV1.6
/–) lacking the expression of the Na1
channel gene,Scn8a, INa were not detected in dispersed smoothmuscle cells from the vas deferens, while TTX-sensitive INa were
recorded in their wild-type (NaV1.6
1/1) littermates. This study demonstrates that the molecular identity of the voltage-gated Na1
channels responsible for the TTX-sensitive INa in murine vas deferens myocytes is primarily NaV1.6.
INTRODUCTION
It is well known that activation of voltage-dependent Ca21
channels and voltage-gated Na1 channels is involved in the
generation of action potentials in various types of excitable
cells (such as nerve ﬁbers, skeletal muscle ﬁbers, and cardiac
myocytes). Although voltage-gated Na1 currents (INa) fail to
be recorded in the vast majority of smooth muscle tissues, in
some smooth muscles, there are several reports regarding the
existence of INa in vascular (rat portal vein, (1); murine portal
vein, (2)) and visceral smooth muscle (rat myometrium, (3);
guinea-pig ureter, (4); sheep lymphatics, (5)), suggesting that
INa are involved in the generation of action potentials. Volt-
age-gated Na1 channels appear to be selectively expressed in
some, but not all smooth muscle, thereby questioning their
signiﬁcance in the physiology of the tissues. Most of INa in
these smooth muscles are sensitive to tetrodotoxin (TTX)
although the potency of the TTX-sensitivity seems to vary
from tissue to tissue. Furthermore, little attention has been
given to the molecular properties of TTX-sensitive INa in
freshly dispersed smooth muscle myocytes.
Recent studies have revealed that voltage-gated Na1
channels consist of three subunits (expressed as a trimer):
namely, an a-subunit (260 kDa) that forms the core protein
of the channel (possessing the TTX-binding sites) and two
b-subunits (30–40 kDa) that modify the channel function as
an auxiliary subunit. To date, 11 isoforms of genes (Scn1a-
11a) encoding TTX-sensitive and TTX-insensitive Na1
channels have been identiﬁed within a single family of Na1
channels, NaV1.x (6).
It has been reported that in mouse vas deferens, the pres-
ence of the fast TTX-sensitive component contributes to the
rising phase of action potentials (7). In rat vas deferens smooth
muscle cells, TTX-sensitive INa can be detected by use of
conventional whole-cell recordings (8). However, the mo-
lecular and pharmacological properties of INa in the rodent vas
deferens still remain elusive.
In this study, the electrophysiological and pharmacological
properties of fast inward currents in murine vas deferens iso-
lated smoothmuscle cells were investigated using patch-clamp
techniques. Themolecular identity of the TTX-sensitive pore-
forming subunits was revealed using RT-PCR analysis, in situ
hybridization, and immunohistochemistry. Furthermore, INa
were compared in NaV1.6-null mice (motor end-plate disease
(med) mouse, NaV1.6
/–) lacking the expression of the Na1
channel gene, Scn8a, to INa in their wild-type (NaV1.6
1/1)
littermates.
MATERIALS AND METHODS
Cell dispersion
All animal experiments were approved by the animal care and use committee
of Faculty of Medicine, Kyushu University (Fukuoka, Japan). Male Balb/c
mice (8–10 weeks) or C3HeB/FeJ mice (2–3 weeks) were killed by cervical
dislocation. Vasa deferentia were removed and immediately placed in
physiological salt solution (PSS, see below). Myocytes were freshly isolated
by the gentle tapping method (9) and stored at 4C. Relaxed spindle-shaped
cells were normally used for patch-clamp analysis within 3–4 h after isola-
tion.
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Recording and data analysis
Patch-clamp experiments (conventional whole-cell conﬁguration) were per-
formed at room temperature (21–23C), as described previously (10). Glass
pipettes of between 3 and 5 MV were prepared by a micropipette puller
(P-97, Sutter Instruments, Novato, CA). Junction potentials between the bath
and pipette solutions were measured with a 3 M KCl reference electrode and
were under 1 mV, so that correction for these potentials was not made. The
series resistance was compensated at the beginning of each experiment.
The data recording system used was essentially the same as described
previously (10). The whole-cell INa data were ﬁltered at 1 kHz by an eight-
pole Bessel ﬁlter, sampled at 0.1 ms and analyzed on a PowerMac G4 com-
puter (Apple Computer Japan, Tokyo, Japan) using commercial software
(Chart v5.0.2, AD Instruments, Castle Hill, Australia).
Steady-state inactivation of INa was assessed using a two-step protocol
where the cells were stepped from 70 mV to a range of voltages between
120 and140 mV for a period of 2 s before a 200 ms step to 10 mV. The
peak amplitude of INa evoked by each test pulse was measured and the peak
amplitude of INa without application of any conditioning pulse was normal-
ized as one. The lines were drawn by ﬁtting the data to the Boltzmann’s
equation using the least-squares method,
I ¼ ðImaxÞ=f11 exp½ðV  VhalfÞ=kg;
where I, Imax, V, Vhalf, and k are the relative amplitude of INa observed at
various amplitudes of the conditioning pulse (I) and observed after the appli-
cation of a conditioning pulse of70 mV (Imax), amplitude of the condition-
ing pulse (V), and,where the amplitude of INawas reduced to half (Vhalf), slope
factor (k).
Activation curves were derived from the current-voltage relationships.
Conductance (G) was calculated using the equation
G ¼ INa=ðEm  ENaÞ;
where INa is the peak current elicited by depolarizing test pulses from60 to
140 mV from the holding membrane potential of 70 mV and ENa is the
equilibrium potential for Na1. Gmax is the maximal Na
1 conductance
(calculated at potentials above 10 mV). The G/Gmax ratios were plotted
against the membrane potential as relative amplitudes.
Drugs and solutions
The following solutions were used: PSS containing (mM): Na1 140, K1 5,
Mg21 1.2, Ca21 2, glucose 5, Cl 151.4, HEPES 10, titrated to pH 7.35–7.40
with Tris base. The composition of the pipette solutions was (mM): Cs1 130,
tetraethylammonium (TEA1) 10, Mg21 2, Cl 144, glucose 5, EGTA 5,
ATP 5, HEPES 10/Tris (pH 7.35–7.40). Cells were allowed to settle in the
small experimental chamber (80 ml in volume). The bath was superfused by
gravity throughout the experiments at a rate of 2 ml min1 from a solution
reservoir. Efonidipine (kindly provided by the Nissan Chemical Industries,
Funabashi, Japan), mibefradil, nifedipine, and veratridine (from Sigma-
Aldrich Japan, Tokyo, Japan) were prepared daily as 100 mM stock solutions
in dimethylsulphoxide. The ﬁnal concentration of dimethylsulphoxide was
,0.03% and this concentration of solvent did not affect control membrane
currents. Tetrodotoxin (TTX, Sankyo, Tokyo, Japan) and kurtoxin (Peptide
Institute, Osaka, Japan) were dissolved in deionized water, aliquoted, and
stored frozen (20C).
RNA preparation and reverse
transcription-polymerase chain reaction analysis
Total RNA was isolated from vas deferens tissue using CONCERT cyto-
plasmic RNA Puriﬁcation Reagent (Invitrogen, Carlsbad, CA). First-strand
cDNA was synthesized from 4 mg of total RNA using 200 U Superscript II
Reverse Transcriptase (Invitrogen). The PCR reaction was performed using
1 ml of cDNA in 45 ml PCR SuperMix High Fidelity (Invitrogen) containing
0.5 mM of each primer. After denaturing at 94C for 2 min, the cycling
conditionswere 94C for 15 s, annealing 65C for 30 s, and 72C for 1min for
35 cycles and then ﬁnal extension at 72C for 10 min. An aliquot of the
RT-PCR product (10ml) was analyzed on a 2% agarose gel. Generic subunit-
speciﬁc primers (Scn2a, 3a, 5a, 10a, and 11a) were designed based on in-
formation from murine sequences and the locations of the primers indicated
are based on the subunit sequence information obtained fromGenBank (Table
1). Scn1a, 4a, 8a, and 9a were adapted from Saleh et al. (2) (for primers see
Table 1). Control reactions were carried out in the absence of reverse tran-
scriptase to ensure that the detected products were not the result of possible
DNA contamination and by use of corresponding templates as positive
controls to ensure that the primerswere annealing successfully. All amplicons
were of the expected sizes and their identity was conﬁrmed byDNA sequence
analysis.
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as described (11). Brieﬂy,
murine Scn8a digoxigenin-labeled ‘‘sense’’ and ‘‘antisense’’ RNA probes
were produced from cDNA fragment corresponding to position 241–779 of
the Scn8a cDNA sequence according to GenBank accession No. NM_
011323. The cDNA fragment isolated frommurine cerebellum cDNA library
by PCR using 59-CTG GAG GAC TTT GAC CCG TAC TAT-39 (Forward)
and 59-AAC ACC GTC AGG ATC ATC ACG TCT-39 (Reverse) primers,
was subcloned into pCR II-TOPO (Invitrogen). The probes were labeled with
theDIG-RNA labeling kit (RocheDiagnostics, Indianapolis, IN) according to
manufacturer’s instruction and used at a 1:1000 dilution in hybridization
buffer. Vasa deferentia dissected from adult mice were subjected to overnight
hybridization with the riboprobes at 70C, and subsequently incubated with
anti-DIGFab fragments (RocheDiagnostics) overnight at 4C.Detectionwas
TABLE 1 Nucleotide sequences for the custom designed primers used to detect the voltage-gated Na1 channel gene isoforms
in RT-PCR
Gene name REFseq ID Primer sequence (59 to 39) Gene name REFseq ID Primer sequence (59 to 39)
Scn1a AJ810515 F-AGCCTCACTGTGACTGTGCC Scn8a NM_011323 F-GGGAGGACGATGAAGACAG
R-CTATTCGGAAGCACGTCCTCC R-TCAGGCAGAACACCGTCAG
Scn2a L42341 F-GCTTATCTCACTCCGTCATT Scn9a XM_196271 F-CAGCAAAGAGAGACGGAACC
R-ACAATCGGGAGGTCCACTAT R-CCCTCAGTGTCCGTAGAGATT
Scn3a NM_018732 F-TGTGCTGAAATAACGACTTG Scn10a NM_009134 F-TGTTGTGTGGCAATGGATCT
R-TTCACATAATCAATCCCCTT R-GCACCTCCTGTTCTTTCTGC
Scn4a NM_133199 F-CATCAAATCCCTGCGCACGC Scn11a NM_011887 F-CAGCTTTGGCTGGTCTTTTC
R-ATAAAGATGACGAAGTAAAGG R-CCTCCTTTTCCTCCCTCAAC
Scn51a NM_021544 F-ACCACGGTTACACCAGCTTC
R-CCTCGTGTTCCTTCTTGAGC
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performedwith staining buffer containing nitroblue tetrazoliumand5-bromo-
4-chloro-3-indolyl-phosphate (RocheDiagnostics). After staining for 30min,
the sampleswere sliced bymicrotome (Leica,Nussloch,Germany) to a 20mm
thickness and the staining was observed by BioZero microscopy (Keyence,
Osaka, Japan).
Immunohistochemical studies
Vasa deferentia and cerebrum were embedded in a mixture (2:1) of optimal
cutting temperature compound (Tissues-Tek, Sakura, Tokyo, Japan) and 20%
sucrose in phosphate-buffered saline (PBS). Tissues in the embedding me-
dium were immediately frozen in liquid nitrogen-cooled hexane. Frozen
sections were cut with a cryostat (CM3050S, Leica, Tokyo, Japan) to 6 mm
thick sections, andweremounted on silane-precoated glass slides and allowed
to dry in air at room temperature for ;30 min. Sections were ﬁxed in cold
acetone for 5 min and washed thoroughly in PBS, permeabilized and blocked
with blocking solution (5% fat-free milk, 2% bovine serum albumin (BSA),
and 0.1% Triton-X 100 in PBS) for 60 min at room temperature. Primary
puriﬁed rabbit anti-NaV1.x antibodies (i.e., anti-NaV1.1 antibody, anti-
NaV1.2 antibody and anti-NaV1.6 antibody, respectively) were purchased
from Chemicon International (Temecula, CA). After washing, sections were
incubated with the primary puriﬁed rabbit anti-NaV1.x antibody and diluted
(1:200) in 1% BSA and 0.1% Triton-X 100 in PBS at 4C overnight in a
humidiﬁed chamber. As a negative control, the primary antibody was ab-
sorbed with the peptide against which it was made (i.e., blocking peptide).
After washing three times (5 min each) in PBS, endogenous peroxidase ac-
tivity was quenched with 0.3% H2O2 in methanol for 30 min. Sections were
washed in PBS and then reacted with Envision system labeled polymer-
horseradish peroxidase anti-rabbit (Dako Cytomation, Carpenteria, CA) for
30 min at room temperature, and visualized with 3,39diaminobenzidine
(Dojin Chemicals, Kumamoto, Japan) with 0.01% H2O2. Sections were de-
hydrated and coverslipped in mounting material (MGK-S, Matsunami Glass,
Osaka, Japan).
In immunoﬂuorescence studies, sections were incubated with the primary
puriﬁed rabbit anti-NaV1.x antibody (i.e., anti-NaV1.1 antibody, anti-NaV1.2
antibody, and anti-NaV1.6 antibody, respectively) as described, and the pri-
mary antibodywas absorbed with the peptide against which it was made (i.e.,
blocking solution; 2% goat IgG, 1% BSA, and 0.1% Triton-X 100 in PBS).
After washing in PBS (three washes for 5 min each), sections were incubated
with phycoerythrin-conjugated goat anti-rabbit IgG (sc-3752; Santa Cruz
Biotechnology, Santa Cruz, CA) diluted to 1:30 in PBS with 2% normal goat
serum, 1% BSA, and 0.1% Triton-X 100 in PBS for 1 h at room temperature
under dark conditions. Sectionswere thenwashed in PBS a further three times
(5 min duration each). Coverslips were mounted onto slides by use of ﬂuo-
rescence mounting medium and slides were viewed by ﬂuorescent micros-
copy (Biozero BZ-8000, Keyence). Mouse cerebrum was used as a positive
control for anti-NaV1.1 and anti-NaV1.2 antibodies.
NaV1.6-null mice
Heterozygous Scn8a-motor end-plate disease (med) mice maintained on a
C3HeB/FeJ background were obtained from The Jackson Laboratories (Bar
Harbor, ME). The med mutation produces complete loss of NaV1.6 expres-
sion. To compare animals homozygous for med (NaV1.6
/–) with wild-type
(NaV1.6
1/1) littermates, genotyping was performed with individual pups
from the intercrosses of heterozygote (NaV1.6
1/–) mice, and then NaV1.6
/–
or NaV1.6
1/1 mice were selected for further examination. Genotyping of
NaV1.6 was performed by PCR as described previously (12). PCR ampliﬁ-
cation was achieved with 35 cycles of 94C for 30 s, 58C for 30 s, and 72C
for 30 s using the following speciﬁc primers: for the wild-type allele, 59-GGA
GCAAGGTTCTAGGCAGCTTTAAGTGTG-39 and 59-GTCAAAGCC
CCG GAC GTG CAC ACT CAT TCC-39 and for the mutant allele, 59-TCC
AATGCTATACCAAAAGTC CC-39 and 59-GGACGTGCACAC TCA
TTCCC-39. PCRproductswere separated on a 1.5%agarose gel, allowing the
resolution of a 230-basepair product for the wild-type allele and a 194-
basepair product for the mutant allele.
Statistics
Statistical analyses were performed using analysis of variance tests (two-
factor with replication). Changes were considered signiﬁcant at P, 0.05 (*,
P , 0.05; **, P , 0.01). Data are expressed as mean with the standard
deviation (mean 6 SD).
RESULTS
Depolarization elicits three types of inward
currents in murine vas deferens myocytes
After establishing a conventional whole-cell conﬁguration in
smooth muscle cells freshly isolated from murine vas def-
erens, application of a depolarizing step to 10 mV from a
holding potential of 70 mV produced an inward current,
which reached a peak and then gradually decayed (Fig. 1 A).
Application of nifedipine (10 mM) dramatically reduced the
peak amplitude of the inward current. In the presence of ni-
fedipine, a transient inward current superimposed upon a
slowly inactivating component was obtained. Further appli-
cation of Cd21 (100 mM) abolished the slow components of
the current, leaving a fast transient component (Fig. 1 A).
To classify these components, a method for pharmaco-
logical subtraction of the leak and the capacitive currents was
performed (10). As shown in Fig. 1 B, subtracting the current
in the presence of nifedipine (10mM) from the control current
yielded a nifedipine-sensitive inward current, which was
evoked at potentials more positive than 40 mV. The maxi-
mum peak amplitude was obtained at ;10 mV and was
reduced at more positive potentials, showing a bell-shaped
current-voltage relationship (Fig. 1C). Subtracting the current
in the presence of nifedipine (10 mM) and Cd21 (100 mM)
from that in the presence of nifedipine alone yields a nifedi-
pine-insensitive but Cd21-sensitive inward current. This
current appeared at potentialsmore positive than40mV and
peaked at 0 mV, demonstrating a bell-shaped current-voltage
relationship (Fig. 1 C). By subtracting the current in the
presence of TTX (1 mM), nifedipine (10 mM) and Cd21 (100
mM) from that in the presence of nifedipine and Cd21, a TTX-
sensitive component was obtained.
To examine the possibility that TTX-resistant Na1 cur-
rents were included in the nifedipine-insensitive and Cd21-
sensitive component, the electrophysiological properties of
the Cd21-sensitive component were investigated in the
presence of TTX (1 mM) and nifedipine (10 mM). Fig. 2 A
shows the time course when the extracellular Na1 concen-
tration in the bath solution was changed to an isoosmotic
solution of TEA1. When extracellular Na1 was replaced
with TEA1, the peak amplitude of the nifedipine-insensitive
and TTX-resistant inward current was not affected (n ¼
seven, three different animals). Similar results were obtained
when the same amount of Na1 was replaced with Tris1 (n¼
six cells, three different animals, Fig. 2 B) or N-methyl-
D-glucamine (NMDG1) (n ¼ six cells, three different ani-
mals, Fig. 2 B). The nifedipine-insensitive and TTX-resistant
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inward currents were abolished by subsequent application of
Cd21. These results suggest that the nifedipine-insensitive,
TTX-resistant and Cd21-sensitive component seems to pos-
sess no Na1 permeability. Since TTX-resistant Na1 currents
are reported to be highly Cd21-sensitive (13,14), RT-PCR
was performed to determine the presence of TTX-resistant
Na1 channel genes (Scn5a, Scn10a, and Scn11a). Speciﬁc
primers for the ampliﬁcation were designed to produce
cDNA fragments to each isoform gene for a-subunits (see
Table 1). Positive amplicons for Scn5a (heart cells), 10a
(dorsal root ganglion) and 11a (dorsal root ganglion) were
detected, whereas in vas deferens, none of amplicons was de-
tected (Fig. 2 C). All amplicons were sequenced to conﬁrm
their identity.
FIGURE 2 No Na1 permeability could be
detected in the nifedipine-insensitive and TTX-
resistant inward current which was blocked by
Cd21. (A) The time course of the inward currents
in the presence of nifedipine (10 mM) and TTX
(1mM)when the extracellular Na1was replaced
with TEA1 (the inward currents were elicited by
repetitive depolarizing pulses from 70 mV to
10 mV). The peak amplitude of the inward
current was measured under each experimental
condition. (B) Columns indicate the relative
mean values of the peak amplitude of the inward
current elicited by a step pulse from 70 mV to
10 mV. The peak amplitude of the inward
current was normalized as one just before extra-
cellular Na1 was replaced with several iso-
osmotic solutions (TEA1, Tris1, and NMDG1).
Data are expressed asmean6 SD (n ¼ 6–7 cells,
three different animals). (C) RT-PCR was per-
formed as described in the Materials and
Methods and a ladder was used to indicate the
size of the ampliﬁed fragments. Speciﬁc primers
for Scn gene isoforms (Scn5a, 10a, and 11a)
were used and mRNA was extracted from
freshly dissected murine heart (H), dorsal root
ganglion (D), and vas deferens (V).
FIGURE 1 Three components of voltage-
dependent inward currents in murine vas defer-
ens myocytes. (A) Representative current traces
in the absence and presence of several drugs
(nifedipine (10 mM), Cd21 (100 mM), and TTX
(1 mM), respectively) measured using a conven-
tional whole-cell conﬁguration. The bath solu-
tion was PSS and the recording pipette was ﬁlled
with a Cs1-TEA1 solution containing EGTA
(5 mM). Each current was evoked by 200 ms
depolarization steps from a holding potential of
70 to10mV. (B) Three different components
of voltage-dependent inward currents, namely, a
nifedipine-sensitive component, a nifedipine-in-
sensitive but Cd21-sensitive component, and a
TTX-sensitive component. The nifedipine-sen-
sitive component was obtained by subtracting
the current recorded in the presence of nifedipine
(10 mM) from the control current recorded in the
absence of drugs. The nifedipine-insensitive but
Cd21-sensitive component was obtained by
subtracting the current recorded in the presence
of nifedipine (10 mM) and Cd21 (100 mM) from
the current in the presence of nifedipine (10mM)
alone. The TTX-sensitive component was obtained by subtracting the current in the presence of nifedipine (10mM), Cd21 (100mM), and TTX (1mM) from the
current in the presence of only nifedipine and Cd21. (C) Current-voltage relationships of the three components obtained in panel B from the same cell. The peak
amplitude of the membrane current was measured in each condition.
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TTX-sensitivity of the transient inward currents
To characterize further the transient TTX-sensitive inward
current, in a series of experiments, Cd21 (100 mM) was
added to the bath solution. The peak amplitude of the tran-
sient TTX-sensitive inward current was maintained for at
least 30 min when test depolarization pulses were applied at
20 s intervals (the peak amplitude of the transient inward
current at 20 min being 98% (n ¼ 37 cells, 12 different an-
imals) of the value determined after reaching steady state).
Therefore, all experiments were performed within 20 min
after the peak amplitude of the transient TTX-sensitive in-
ward current had become stable at 70 mV. In the presence
of 100 mM Cd21, TTX caused a concentration-dependent
inhibition of the transient inward current (Kd¼ 11.2 nM; n¼
4–10 cells, Fig. 3, B and C). On removal of TTX, this in-
hibitory action was reversed to the control level.
Voltage-dependent properties of the transient
inward current
The transient TTX-sensitive inward current shows rapid ac-
tivation and inactivation. The decay of the transient inward
current was ﬁtted to a single exponential in the whole range of
potentials studied (Fig. 4 A). The time constant of the current
decay (t) decreased monotonically from 4.06 0.8 ms at20
mV to 0.7 6 0.1 ms at 110 mV (Fig. 4 B). The steady-state
inactivation and activation curves for the transient TTX-
sensitive inward currents were obtained (conditioning pulse
duration, 2 s; holding membrane potential, 70 mV). Inac-
tivation of the transient TTX-sensitive inward currents oc-
curred with conditioning pulses positive to 60 mV and the
50% inactivation potential (Vhalf), evaluated by ﬁtting to the
Boltzmann’s equation, was 46.3 6 0.6 mV (n ¼ ﬁve cells,
three different animals). The activation curves were obtained
from the current-voltage relationships ﬁtted to the Boltzmann’s
equation, and the 50% activation potential (Vhalf) was26.06
0.7 mV (n ¼ seven cells, ﬁve different animals). The aver-
age activation and inactivation values are summarized in
Fig. 4 C.
Na1 serves as a charge carrier for the transient
inward currents
To estimate the ion selectivity of the TTX-sensitive transient
inward currents, extracellular Na1 concentration was
changed to an isoosmotic solution of TEA1. When extracel-
lular Na1was replaced with TEA1, the peak amplitude of the
TTX-sensitive transient inward currents markedly decreased
(Fig. 5, A and B) and on reintroduction and removal of TEA1,
the peak amplitude of the TTX-sensitive transient inward
current readily recovered to the control level (Fig. 5,A and B).
Similar results were obtained when the same amount of Na1
was replaced with Tris1 or NMDG1 (data not shown). These
results suggest that the TTX-sensitive transient inward current
is carried mainly by Na1 (Fig. 5 C, n ¼ ﬁve cells, three dif-
ferent animals).
FIGURE 3 The effects of TTX on the tran-
sient inward currents. (A) Representative traces
of the transient inward currents eliminated by
preapplication of nifedipine (10 mM) and Cd21
(100 mM) with increasing concentrations of
TTX. (B) Concentration-response relationship
for TTX on the transient inward currents. The
peak amplitude of the transient inward current
elicited by a step pulse to 10 mV from a
holding potential of 70 mV just before appli-
cation of TTX was normalized as one (i.e.,
control). The curve was drawn by ﬁtting the
following equation using the least-squares
method: Relative amplitude of the transient in-
ward current¼ 1/f11 (D/Kd) nHg, whereKd,D,
and nH are the inhibitory dissociation constant,
the concentration of TTX (nM), and Hill’s coef-
ﬁcient, respectively. The following values were
used for the ﬁtted curve:Kd¼ 11.2 nM, nH¼ 1.0.
Each symbol indicates the mean of 4–10 obser-
vations with the mean 6 SD shown by the
vertical lines. Some of the SD bars are smaller
than the symbol. (C) The current-voltage rela-
tionships in the absence and presence of TTX (10
nM) when Cd21 (100 mM) was present. The
current amplitude was measured as the peak
amplitude of the transient inward current at each
membrane potential.
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Pharmacological properties of the transient
TTX-sensitive inward INa
As summarized in Fig. 5 D, the effects of several channel
blockers (Ni21, Cd21, efonidipine and kurtoxin) on the peak
amplitude of the TTX-sensitive transient inward INa were
investigated. None of the channel blockers had a signiﬁcant
effect on the amplitude of the inward current; however, ve-
ratridine, an activator of voltage-gated Na1 channels, en-
hanced the peak amplitude of the TTX-sensitive transient
inward INa in a concentration-dependent manner (1–10 mM).
In contrast, mibefradil inhibited the peak amplitude of the
transient inward current in a concentration-dependent manner
(Kd ¼ 3.3 mM; n ¼ 4–6 cells, Fig. 5 E).
Molecular expression of Na1 channels
To determine the molecular nature of voltage-gated Na1
channels, samples of RNA were obtained from murine heart
and vas deferens. It is well established that six isoforms of
genes for voltage-gated Na1 channels (Scn1a, 2a, 3a, 4a, 8a,
and 9a) are highly TTX-sensitive (6). Since INa in murine vas
deferens were abolished by TTX, these results strongly sug-
gest that TTX-sensitive voltage-gated Na1 channels are
functionally expressed in that tissue. To investigate the pre-
cise subtype of channel present, speciﬁc primers for the am-
pliﬁcation of TTX-sensitive voltage-gated Na1 channels
were designed to produce cDNA fragments to each isoform
gene for a-subunits (Scn1a, 2a, 3a, 4a, 8a, and 9a, see Table
1). Positive amplicons for Scn1a, 2a, 3a, 4a, and 8a were
detected in cardiac myocytes, while in vas deferens, only
Scn1a, 2a, and 8a were detected (Fig. 6 A). All amplicons
were sequenced to conﬁrm their identity.
Expression of Scn8a mRNA
To study the distribution of Scn8a mRNA throughout the
mouse vas deferens organ, whole-mount in situ hybridiza-
tion was performed in ﬁxed tissue using Scn8a-speciﬁc
DIG-labeled sense and antisense riboprobes. The antisense
riboprobe displayed distinct intense markings in smooth
muscle layer tissues compared with sense probes, suggesting
that smooth muscle myocytes are candidates for Scn8a ex-
pression (Fig. 6, B and C).
Immunohistochemical localization of NaV1.6
To localize a molecular marker for NaV1.6, immunohisto-
chemical studies were performed. NaV1.6 immunoreactivity
is clearly visible in the smooth muscle layers of the vas
deferens (Fig. 7 A), while no speciﬁc immunoreactive signal
was seen when the primary antibody was preabsorbed with
the immunizing NaV1.6 antigen (Fig. 7 B). Immunohisto-
chemistry using nonimmune rabbit IgG instead of primary
antibody also gave a negative result (data not shown). Sim-
ilarly, as shown in Fig. 7 C, NaV1.6 immunoreactivity is
clearly visible in the smooth muscle bundles. In contrast, no
speciﬁc immunoreactive signal was seen when the primary
antibody was preabsorbed with the immunizing NaV1.6 an-
tigen (Fig. 7 D). Although Scn1a and Scn2a amplicons were
detected in the vas deferens, note that immunoactivity of
NaV1.1 (Fig. 8 A) and NaV1.2 (Fig. 8 C) were not detected
in the smooth muscle layers of murine vas deferens,
but immunoactivity of NaV1.1 (Fig. 8 B) and NaV1.2 (Fig.
8 D) were clearly visible in mouse cerebrum as a positive
control.
FIGURE 4 Voltage-dependent activation and
inactivation of the transient inward currents. (A)
The declining phase of the transient inward
current elicited by pulses from the holding po-
tential of 70 mV to each indicated membrane
potential (20,10, 0, and110 mV) was ﬁtted
to a single exponential (mean inactivation time
constant (t), 4.3, 1.3, 0.9, and 0.6 ms, respec-
tively). (B) Each column shows the mean value
of the time constant (t) of the transient inward
current measured at each membrane potential
with mean 6 SD (n ¼ ﬁve cells). (C) The ac-
tivation and the steady-state inactivation curves
of the transient inward currents. The steady-state
inactivation curve was obtained using a double
pulse protocol, ﬁtting to the Boltzmann’s equa-
tion (see Materials and Methods). Each symbol
indicates the mean of ﬁve observations with
mean 6 SD. The activation curve was obtained
from the current-voltage relationship of the tran-
sient inward current, ﬁtting to the Boltzmann’s
equation (see Materials and Methods). Each
symbol indicates themean of seven observations
with mean 6 SD. Some of the SD bars are
smaller than the symbol.
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NaV1.6-null mice (med mouse) lacking
expression of Na1 channel gene Scn8a
To investigate further the molecular and functional contri-
butions of INa in smooth muscle cells from murine vas def-
erens, homozygous mice with a null allele of NaV1.6 (med
mice, NaV1.6
/–; (15)) were used. As shown in Fig. 9 A, in
wild-type mice (NaV1.6
1/1), TTX-sensitive INa were evoked
by application of depolarizing rectangular pulses from a
holding potential of 70 mV (n ¼ ﬁve, three different
animals), showing similar electrophysiological and pharma-
cological properties (voltage-dependency in Fig. 9 B, TTX-
sensitivity (Kd ¼ 10.1 nM; n ¼ 5–6 cells) etc.) with those
recorded in Balb/c mice. Conversely, in NaV1.6
/– mice, INa
were not detected (n ¼ seven, three different animals; Fig.
9 A). These results imply that the molecular properties of
INa observed in vas deferens smooth muscle cells are closely
related to NaV1.6.
DISCUSSION
In this study, it has been demonstrated that voltage-depen-
dent inward currents in freshly dispersed smooth muscle cells
from mouse vas deferens consist of three different compo-
nents, namely, a fast activating current followed by two types
of slow activating currents. This work establishes that the fast
component of inward current ﬂows through TTX-sensitive
FIGURE 5 Ion-selectivity and pharmacological properties of the transient inward currents. (A) The time course of the transient inward currents when the
extracellular Na1 was replaced with TEA1 (the transient inward currents were elicited by repetitive depolarizing pulses from 70 mV to 10 mV). The peak
amplitude of the transient inward current was measured under each experimental condition. (B) Original current traces before (control, (a)), after application of
Na1-free solution, (b) and washout (c) as indicated in A. (C) Columns indicate the relative mean values of the peak amplitude of the transient inward current
was elicited by a step pulse from70 mV to10 mV. The peak amplitude of the transient inward current was normalized as one just before extracellular Na1
was replaced with isoosmotic solution of TEA1. Asterisks indicate a statistically signiﬁcant difference, demonstrated using a paired t-test (P, 0.01). Data are
expressed as mean6 SD (n¼ ﬁve cells). (D) Histogram summarizing the relative effects of various blockers and activators on the peak amplitude of the TTX-
sensitive Na1 current in the presence of 100 mMCd21. The peak amplitude of the TTX-sensitive Na1 current was normalized as one just before the application
of divalent cations and drugs (i.e., control). Ni21 (100–300 mM; n ¼ four cells), Cd21 (up to 500 mM; n ¼ six cells), efonidipine (1–10 mM; n ¼ four cells),
kurtoxin (100 nM; n¼ six cells), and veratridine (1–10mM; n¼ six cells). Each column shows the relative amplitude of the inward current (mean value6 SD).
Asterisks indicate a statistically signiﬁcant difference, using a paired t-test (P , 0.01). (E) Relationships between relative inhibition of the peak amplitude of
the transient inward current and the concentration of mibefradil. The peak amplitude of INa was elicited by a step pulse to 10 mV from 70 mV. The curve
was ﬁtted using following equation and the least-squares method: Relative amplitude of the transient inward current ¼ 1/f1 1 (D/Kd) nHg, where Kd, D, and
nH are the dissociation constant, concentration of mibefradil (mM), and Hill’s coefﬁcient, respectively. The following values were used for the ﬁtted curve:
Kd ¼ 3.3 mM, nH ¼ 1.0, and n ¼ 4–6 cells.
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voltage-gated Na1 channels in murine vas deferens smooth
muscle cells, and that the molecular identity of these channels
is likely to be NaV1.6.
Characterization of voltage-gated Na1 channels
These observations regarding the electrophysiological and
pharmacological properties of the fast component of the in-
ward current can be summarized as follows:
1. The fast component of the inward current was abolished
by TTX (Kd ¼ 11.2 nM) and substitution of Na1 with
TEA1, Tris1, and NMDG1.
2. The peak amplitude of the fast component was enhanced by
veratridine, a selective voltage-gatedNa1 channel activator,
in a concentration-dependent manner (1–10 mM).
3. The peak amplitude of the fast component was not
sensitive to Ni21 (100–300 mM), Cd21 (500 mM),
FIGURE 6 Molecular identiﬁcation of voltage-
gated Na1 channel subunits expressed in mouse vas
deferens. (A) RT-PCR was performed as described
in the Materials and Methods and a ladder was used
to indicate the size of the ampliﬁed fragments.
Speciﬁc primers for Scn gene isoforms (Scn1a,
2a, 3a, 4a, 8a, and 9a) were used and mRNA was
extracted from freshly dissected murine heart (H)
and vas deferens (V). (B) Whole-mount in situ
hybridization with a DIG-labeled Scn8a antisense
probe revealed Scn8a expression in the smooth
muscle layers. Arrows indicate the positive signals
in smooth muscle myocytes. Black bar represents
100 mm. (C) The expanded ﬁgure in panel B. Solid
bar represents 30 mm. (D) No staining is obtained
with the Scn8a sense riboprobe used as a control.
Solid bar represents 100 mm. (E) The expanded
ﬁgure in panel D. Solid bar represents 30 mm.
FIGURE 7 Fluorescent images of immunoreactivity for
NaV1.6 in the smooth muscle layers of mouse isolated vas
deferens. (A) NaV1.6 immunoactivity; clear membranous
staining was observed in the tissues of the smooth muscle
layer. (B) Negative-control: use of NaV1.6 antibody pre-
absorbed with the immunizing antigen (BP) never yields
immunostaining. Bar (solid line) represents 100 mm. (C)
NaV1.6 immunoactivity; clear membranous staining was
observed within the smooth muscle layers of murine vas
deferens. (D) Negative-control: use of NaV1.6 antibody
preabsorbed with the immunizing antigen (BP) never
yielded immunostaining. Open bar represents 100 mm.
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efonidipine (1–10 mM), kurtoxin (100 nM), and nifedi-
pine (10 mM).
4. The fast component of the inward current shows fast
kinetics in both its activation and inactivation in bio-
physical properties.
5. The decay of the inward current was voltage-dependent,
with rapid inactivation between 20 mV and 110 mV.
Taken together, the fast component of the inward current in
murine vas deferens appears to be carried through the TTX-
sensitive voltage-gated Na1 channels. The two slow acti-
vating components of voltage-dependent inward currents
were shown to be voltage-dependent Ca21 currents since
both were abolished by Cd21 (100 mM) and substitution of
Ca21 with Co21 (2 mM). One of the slow activating com-
ponents was a nifedipine-sensitive Ca21 current (i.e., L-type
Ca21 current). In contrast, another slow activating compo-
nent of the voltage-dependent inward currents was a nifedi-
pine-insensitive inward current.
It has been reported that TTX-resistant voltage-gated Na1
channels, such as NaV1.8 and NaV1.9, were blocked greatly
by Cd21 (13,14). Thus, in these experiments, the electro-
physiological and molecular properties of the nifedipine-in-
sensitive and TTX-resistant inward current, which was
abolished by Cd21, were investigated. The peak amplitude of
the inward current was not affected by isometric substitution
of Na1with TEA1, Tris1 and NMDG1, suggesting a lack of
Na1-permeable component. In RT-PCR analysis, the three
TTX-resistant voltage-gated Na1 channel amplicons (Scn5a,
10a, and 11a) were not detected in mRNA signal level. These
results suggest that TTX-resistant voltage-gated Na1 chan-
FIGURE 8 Comparative ﬂuorescent images of immuno-
reactivity for NaV1.1 and NaV1.2 in both the smooth muscle
layers of mouse isolated vas deferens and mouse cerebrum.
(A) No NaV1.1 immunoactivity within the smooth muscle
layers of murine vas deferens. (B) Positive control: use
of NaV1.1 antibody in murine cerebrum. (C) No NaV1.2
immunoactivity within the smooth muscle layers of murine
vas deferens. (D) Positive control: use of NaV1.2 antibody in
murine cerebrum. Open bar represents 100 mm.
FIGURE 9 Comparison of electrophysiological
properties of the transient inward currents in
NaV1.6
/ and NaV1.6
1/1 murine vas deferens
myocytes. (A) Representative traces of the transient
inward currents eliminated in the presence of 10 mM
nifedipine and 100 mM Cd21 at the indicated mem-
brane potentials. (B) The current-voltage relation-
ships in NaV1.6
/ and NaV1.6
1/1 mice when
10 mM nifedipine and 100 mM Cd21 were present.
The current amplitude was measured as the peak
amplitude of the transient inward current at each
membrane potential.
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nels were not included in the nifedipine-insensitive and TTX-
resistant inward current in mouse vas deferens myocytes.
In the presence of TTX and nifedipine, Holman et al. (7)
demonstrated that small but signiﬁcant amplitudes of action
potentials were detectable in murine vas deferens. If the ni-
fedipine-insensitive Ca21 currents measured in this study are
contributing to action potentials in murine vas deferens, this
might account for Holman’s observations. Interestingly, in
rat vas deferens, the nifedipine-insensitive Ca21 current was
not observed; only the presence of the nifedipine-sensitive
Ca21 currents (8). Further studies are needed to clarify the
nature and properties of the nifedipine-insensitive and TTX-
resistant inward currents in the vas deferens.
Similarities and differences between the
functional properties of voltage-gated Na1
channels in vascular and visceral
smooth muscles
Recently, electrophysiological and molecular properties of
INa in smooth muscle cells freshly isolated frommurine portal
vein have been characterized and TTX inhibited the peak
amplitude of INa with a similar potency to that in the vas
deferens ((2); murine portal vein, Kd ¼ 12 nM; murine vas
deferens,Kd¼ 11 nM). Apart from the TTX-sensitivity, INa in
vas deferens have many different properties compared to
those measured in portal vein. For instance, mibefradil (100
mM) caused no effect on INa in portal vein (2) while INa in the
vas deferens were abolished by mibefradil in a concentration-
dependent manner (Kd ¼ 3.3 mM). Interestingly, in recom-
binant voltage-gated Na1 channel studies, it has been shown
that mibefradil suppresses TTX-sensitive (NaV1.2, NaV1.4,
NaV1.7; (16)) and TTX-insensitive Na
1 channels (NaV1.5;
(16,17)), showing Kd values at submicromolar concentra-
tions. In murine portal vein, Vhalf values of inactivation and
activation for INa were shown to be 15 mV and 52 mV,
respectively. Conversely, in murine vas deferens, Vhalf values
of inactivation and activation of INa were 46 mV and 26
mV, respectively, showing the different biophysical proper-
ties of voltage-gated Na1 channels. Although the decay of INa
was voltage-dependent in both tissues, the values of the in-
activation time constant (t) at each membrane potential (from
10 mV to 120 mV) in portal vein were much larger than
those in vas deferens. It is not clear, however, whether this
difference is related to the different space-clamp speed due to
the different recording modes of patch-clamp techniques
(amphotericin B-perforated patch versus conventional whole-
cell mode). In murine portal vein, the TTX-sensitive INa,
which were resistant to nicardipine (1 mM) or Cd21 (1 mM),
were observed in 16% of cells (30 from 192 cells). However,
most of the smooth muscle cells from the vas deferens show
TTX-sensitive INa (;95%, 98 from 103 cells), suggesting a
much higher channel density. In the murine portal vein, a
signiﬁcant membrane hyperpolarization (10 mV) was evoked
by the application of TTX. In contrast, TTX consistently
caused depolarization (9 mV) in murine vas deferens using
microelectrode techniques (7), although it is not certain
whether the discrepancy is related to the difference of the
tissues. Taking into account these results, we suggest that the
properties of INa in the vas deferens are different from those in
the portal veinwith a similar TTX-sensitivity. Furthermore, in
rat vas deferens, biophysical properties of TTX-sensitive INa
(the values of Vhalf for inactivation and activation were 63
mVand19mV, (8)) were also different from those inmouse
vas deferens, suggesting that the properties of INa may vary
between species.
Molecular properties of voltage-gated Na1
channels in smooth muscles
In cultured human smooth muscle cells, Jo et al. (18) reported
that the expression of Scn9a (coding for NaV1.7) is respon-
sible for the majority of TTX-sensitive INa. Saleh et al. (2)
reported that, in murine portal vein, RT-PCR analysis re-
vealed three voltage-gatedNa1 channel amplicons (Scn7a, 8a
and 9a) in mRNA signal level, in addition to the proteins
encoded by Scn8a (NaV1.6) and Scn9a (NaV1.7). In this
study, Vhalf for inactivation and activation of INa were46mV
and 26 mV, respectively, and were close to those observed
in recombinant NaV1.6, coexpressed with b-subunits (b1 and
b2 subunits,Vhalf for inactivation and activationwere51mV
and 17 mV, respectively (19); b1 subunit, Vhalf for acti-
vation was 26 mV (20)). INa in murine vas deferens also
possess TTX- and mibefradil-sensitivities similar to those in
recombinant NaV1.6. Furthermore, we were able to detect
amplicons of appropriate size and sequence for Scn1a
(NaV1.1), Scn2a (NaV1.2), and Scn8a (NaV1.6), although the
transcript for Scn9a (NaV1.7) was not detected. When a spe-
ciﬁc antibody for each NaV1.x antigen (anti-NaV1.1 antibody
and anti-NaV1.2 antibody)was used, bothNaV1.1 andNaV1.2
immunoreactivities are clearly visible in mouse cerebrum. In
contrast, no immunoactivity of NaV1.1 and NaV1.2 was de-
tected in the smooth muscle layer of murine vas deferens,
suggesting that the channel proteins for NaV1.1 and NaV1.2
are unlikely to be expressed. It is not certain whether other
tissues (such as peripheral nerves) may contaminate the
mRNA sample of vas deferens smooth muscle, and thereby
showing transcripts with mRNA levels which would not
normally be found in the smooth muscles themselves.
In these experiments, we have detected mRNA for Scn8a
and NaV1.6 proteins in smooth muscle layers of mouse vas
deferens, indicating the possible presence of NaV1.6 proteins
in these myocytes. Furthermore, NaV1.6-null mice (med
mouse, NaV1.6
/–), lacking the expression of the Na1
channel gene, Scn8a, were used to investigate the molecular
properties of INa in murine vas deferens, and compared to
currents recorded from NaV1.6
1/1 wild-type and Balb/c
mice. In the presence of nifedipine (10 mM) and Cd21 (100
mM), INa were not detected in NaV1.6
/– mouse vasa defer-
entia, while INa were recorded in NaV1.6
1/1 wild-type lit-
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termates. These results strongly suggest that INa in mouse vas
deferens are primarily due to activation of NaV1.6 channels.
Physiological roles of voltage-gated Na1
channels in smooth muscles
Since voltage-gated Na1 channels in human smooth muscle
cells were only expressed in the culture conditions but not in
freshly dispersed bronchial smooth muscle cells, it is thought
that voltage-gated Na1 channels may be involved in de-
differentiation and proliferation (18). Thus, under various
pathophysiological conditions, such as vascular injury, ath-
erosclerosis, and asthma, the possible expression of voltage-
gated Na1 channels is worth considering. Surprisingly
though, functional expression of INa has also been reported in
a wide variety of freshly isolated smooth muscle cells (see
Introduction).
Holman et al. (7) reported that a small membrane depo-
larization caused an enhancement of voltage-gated Na1
channel activity, thereby inducing an increase of Na1 inﬂux
and intracellular Na1 concentration ([Na1]i). The increase in
[Na1]i alters the driving force for Na
1, the rate of movement
of Na1 by the Na1/K1 pump and then the Na1/Ca21 ex-
change, which may subsequently raise intracellular Ca21
concentration ([Ca21]i) in mouse vas deferens (7). Similarly,
it is reported that voltage-gatedNa1 channels inmurine portal
vein play an important role in modulating contractility
through a mechanism involving reverse mode Na1/Ca21
exchange (2).
In the mouse vas deferens, it is reported that individual
smooth muscle cells are probably coupled electrically, but
that there are few, if any, low resistance pathways in the
longitudinal direction (21). In the mouse vas deferens, the
excitatory junction potential (EJP) amplitude was more var-
iable in surface cells, suggesting that fewer sites contribute to
the EJP and that there is poor or no electrical coupling of small
EJPs (22). Furthermore, recently, it has been reported that
surface smooth muscle cells of the mouse isolated vas def-
erens were poorly electrically coupled, suggesting that sur-
face cells are somewhere toward the electrically uncoupled
extreme (23). It is possible that the activation of INa may be
required to generate sufﬁcient inward current density in a
short period of time to facilitate action potential propagation
within the smooth muscle, given the presumed scarcity of
electrical coupling between cells in the vas deferens. Further
studies are necessary to clarify the precise physiological roles
and signiﬁcance of voltage-gated Na1 channels in smooth
muscles that express them.
In conclusion, we found that voltage-gated inward currents
in smooth muscle cells freshly dispersed from mouse vas
deferens are composed of three different membrane currents;
namely, nifedipine-sensitive currents (L-type Ca21 chan-
nels), nifedipine-insensitive Cd21-sensitive currents, and
TTX-sensitive INa (voltage-gated Na
1 channels; Nav1.6).
This study also provides novel evidence that the Nav1.6
channel is the major TTX-sensitive Na1 channel expressed in
murine vas deferens smooth muscle cells.
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